We said goodbye at the end of 2018 to our first group of trainee data managers from Liberia and Sierra Leone. It has been great to have their skilled input now boosting our 2019 Ebola Data Team. It is all part of the launch of the Ebola Data Platform in Sierra Leone and Liberia – a collaborative eff...

A la fin de l'année 2018, nous avons dit au revoir à notre premier groupe de gestionnaires de données stagiaires du Libéria et de la Sierra Leone. Il a été formidable de pouvoir compter sur leur expertise pour renforcer notre équipe des données Ebola en 2019. Tout cela fait partie du lancement de la...

Deadline for submission: 7 March 2019, 16:00 (GMT)

Carson, Horby, Merson and colleagues promote the importance of developing clinical research networks in low-resource settings as a pillar to epidemic preparedness in a Letter to Lancet Global Health. The CTM&GH researchers are focused on developing capacity and partnerships across settings at highes...

The Wellcome Trust, Malaria Atlas Project (MAP) and Sage Bionetworks have created a new prize for proposals to develop a new insight, tool, or health application using the malaria data held by MAP.

IDDO's malaria platform, WWARN, has published its latest results in the Lancet Infectious Diseases, calling for researchers, policy makers and public health professionals to reopen discussions about the potential for changing the way uncomplicated P. falciparum malaria is treated in some regions. Th...

The Wellcome Trust, Malaria Atlas Project (MAP) and Sage Bionetworks have created a new prize for proposals to develop a new insight, tool, or health application using the malaria data held by MAP.

To celebrate International Women and Girls in Science Day 2019 we asked some of the women of IDDO about their careers in science.

Das and colleagues published in November 2018 a short letter entitled ‘Evidence of Artemisinin-Resistant Plasmodium falciparum Malaria in Eastern India’. In a subsequent paper published in CID, the same group reported the results of a study conducted between 2014–2016 in the same region, where 15 pa...

A recent WWARN individual patient meta-analysis has gathered 18 published and unpublished studies from Africa and Asia to explore the relationships between identified Kelch 13 mutant alleles and delayed parasite clearance. The study results show one P. falciparum specific mutant and 20 pfk13 propell...

Professor Karen Barnes presents WWARN’s approach to equitable data sharing at the Global Forum on Bioethics in Research satellite meeting in South Africa, 13-14 November 2018.

IDDO and the Drugs for Neglected Diseases initiative (DNDi) hosted a symposium for Visceral Leishmaniasis (VL) experts to discuss the benefits of establishing a global VL data platform and refine a research agenda that will explore key scientific questions to enhance care for VL patients and affecte...

A systematic review of 41 scientific studies evaluating the performance and abilities of portable devices to assess the quality of pharmaceutical products has been published today. The review revealed that although there is a wide range of devices available for medicines quality screening, there is ...

A new Piperaquine Pharmacokinetics in Pregnancy Study Group is now open for participation. The analysis hopes to determine the effect of pregnancy on the pharmacokinetic (PK) properties of piperaquine and contribute evidence to inform decisions on the use and optimal dosing of piperaquine in pregnan...

Malaria is the leading cause of parasitic disease, killing nearly half a million people per year, most of whom are African children. Recent figures from the World Health Organization indicate that the decline in the number of infections and deaths annually has stalled. We are once again at a critica...

Over 30 organisations have so far signed the Oxford statement developed by IDDO and the Medicines We Can Trust campaign during the first ever-academic conference on Medicine Quality and Public Health in Oxford, 23-28 September.

Over 40 organisations have so far signed the Oxford statement developed by IDDO and the Medicines We Can Trust campaign during the first ever-academic conference on Medicine Quality and Public Health in Oxford, 23-28 September.

If you’re in Oxford, UK between now and January 4th, 2019 visit the Radcliffe Science Library at the University of Oxford to see a new art exhibition of 14 prints illustrating the global health impact of poor quality medicines.

Researchers from IDDO and the WorldWide Antimalarial Resistance Network (WWARN) presented at the 9th European and Developing Countries Clinical Trials Partnership (EDCTP) forum held in Lisbon, Portugal from 17-21 September 2018.

Quinoline antimalarial drugs are vital tools in the fight against malaria. However, their possible effect on the heart’s rhythm raises safety concerns which may limit their use.